Pancreatic Cysts
512 articles
Immunotherapy Combination Plus Radiation for Pancreatic Cancer
Researchers are testing two monoclonal antibodies approved to treat melanoma plus radiation as a treatment for pancreatic cancer.
Let’s Win Pancreatic Cancer Survivors Series—Year Seven
Our Survivors Video Series is entering Year Seven with even more inspiring stories of taking on pancreatic cancer and life.
Testing a Different Approach to Pancreatic Cancer Treatment
A drug that is epigenetic therapy, which alters how DNA behaves, is being tested in a clinical trial for pancreatic cancer.
Drama Helps Playwright Tackle Pancreatic Cancer Loss
Playwright Isobel Barrett has turned the tragic loss of her husband into a moving play that is also a tool for pancreatic cancer advocacy.
Blood Clots, a Stroke, and Pancreatic Cancer
Mike Emerson underwent a pancreatectomy followed by two years of chemotherapy and radiation but he’s enjoying life now.
Testing a New Drug to Attack Pancreatic Tumor Blood Vessels
A clinical trial is testing a new drug combination that damages the tumor blood vessels and allows chemotherapy drugs to enter the tumor.
Safety and Effectiveness of a New Drug for Advanced Pancreatic Cancer
Researchers are testing dose safety and effectiveness of a new drug for pancreatic cancer, in combination with gemcitabine.
Facebook Live: Why Is Pancreatic Cancer Research Important?
Dr. David Tuveson and Dr. Allyson Ocean discuss the importance of pancreatic cancer research in this video of a Facebook Live chat.
Facebook Live: Early Detection of Pancreatic Cancer
Dr. Anirban Maitra and Dr. Allyson Ocean discuss the status of tests to provide early detection of pancreatic cancer in this video of a Facebook Live chat.
Chemotherapy Plus Stem Cell Infusion and Vitamins for BRCA Mutated Pancreatic Cancer
A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.
PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations
A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
Four-Drug Combination Tested in Metastatic Pancreatic Cancer
A clinical trial is testing a drug combination including a drug used for erectile dysfunction, a new drug, and two immunotherapy drugs.
Let’s Win! Pancreatic Cancer Foundation Appoints Two New Board Members
David Glauber and Sergeant Elvin Howard, Jr., have been appointed to the Let’s Win Board of Directors, effective July 2020.
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.